Race against time: can earlier blood thinner save heart attack patients?
NCT ID NCT07361783
Summary
This large study is testing if giving a common blood-thinning medication (heparin) immediately after diagnosing a major heart attack, rather than later during surgery, leads to better patient recovery. It will involve over 6,200 patients across about 80 hospitals who are scheduled for emergency artery-opening surgery. The main goal is to see if this early treatment reduces the combined risk of death, another heart attack, stroke, or other major heart problems within 30 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ST-ELEVATION MYOCARDIAL INFARCTION (STEMI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Renmin Hospital of Wuhan university
RECRUITINGWuhan, Hubei, 430000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.